Avalet Tablet 20 mg contains Avatrombopag, a thrombopoietin receptor agonist designed to increase platelet production in patients with low platelet counts (thrombocytopenia). This oral medication is primarily used to manage thrombocytopenia associated with chronic liver disease (CLD) in patients scheduled for medical or surgical procedures. Avalet helps elevate platelet levels, reducing the risk of bleeding and improving patient safety during invasive procedures.
Avatrombopag selectively binds to and activates thrombopoietin (TPO) receptors on megakaryocyte precursors in the bone marrow, stimulating platelet production. Unlike platelet transfusions, Avalet provides a non-invasive, targeted approach for managing thrombocytopenia, enhancing patient comfort and reducing procedural complications.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Avalet Tablet 20 mg works through the following mechanism:
TPO Receptor Activation: Avatrombopag binds to thrombopoietin receptors on megakaryocyte precursors, stimulating the maturation of megakaryocytes and increasing platelet production.
Improves Platelet Count: Gradually raises circulating platelet levels, reducing bleeding risk in patients with low platelet counts.
Non-Immunogenic: Unlike transfusions, Avalet does not carry the risk of immune reactions or transfusion-related infections.
By enhancing the body’s natural platelet production, Avalet offers a safe and effective alternative to platelet transfusions for patients at risk of bleeding.
Avalet Tablet 20 mg is indicated for:
Thrombocytopenia in chronic liver disease: To increase platelet counts in patients with CLD scheduled to undergo medical, dental, or surgical procedures
Patients at risk of bleeding due to low platelet counts: To reduce bleeding complications associated with invasive procedures
Avalet is prescribed for adult patients and should be administered under the guidance of a hematologist or physician experienced in managing thrombocytopenia.
The recommended dose is 20 mg orally once daily, usually for 5 consecutive days prior to a scheduled procedure, as directed by a physician.
Swallow the tablet whole with water; do not crush or chew.
Monitor platelet counts before and after treatment to guide dosing and assess response.
Avoid skipping doses, as consistent daily administration is necessary for optimal platelet elevation.
Dose adjustments may be required based on patient response and baseline platelet levels.
Increases platelet count safely and effectively
Reduces the risk of bleeding during medical or surgical procedures
Offers an alternative to platelet transfusions
Convenient oral formulation for outpatient use
Minimizes the need for repeated hospital-based transfusions
Avalet Tablet 20 mg is generally well tolerated. Potential side effects may include:
Headache
Fatigue or weakness
Nausea or gastrointestinal discomfort
Rarely, thromboembolic events (blood clots) in patients with risk factors
Allergic reactions are uncommon
Patients should report any unusual bleeding, clotting, or severe reactions to their healthcare provider immediately.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Not recommended for use in patients with known hypersensitivity to Avatrombopag or any excipients.
Use caution in patients with a history of blood clots or cardiovascular disease.
Avoid use during pregnancy or breastfeeding unless prescribed by a physician.
Regular monitoring of platelet counts is essential to prevent excessive platelet elevation.
Inform your doctor about all medications being taken to avoid potential drug interactions.
Store below 30°C in a cool, dry place, away from light and moisture. Keep out of reach of children.
Avalet Tablet 20 mg (Avatrombopag) is an effective and safe oral therapy for managing thrombocytopenia in patients with chronic liver disease, enhancing platelet counts, and reducing the risk of bleeding during procedures when used under proper medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet